Astraea
AI Operating System for Clinical Development
Assume
Informazioni
Descrizione dell’azienda in inglese
Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, reviewable execution.
Temi
- Sede
- San Francisco, CA, USA
- Team
- 6 dipendenti
- Batch YC
- Spring 2026
- Stato
- Attiva
- Fase
- Fase iniziale
